Evidence map›Paper›PMID 23530018›Full record

ArticleDrug metabolism and disposition: the biological fate of chemicals2013

Chalcogenopyrylium dyes as differential modulators of organic anion transport by multidrug resistance protein 1 (MRP1), MRP2, and MRP4.

Robert L Myette, Gwenaëlle Conseil, Sean P Ebert, Bryan Wetzel, Michael R Detty, Susan P C Cole

Open access · bronzeAbstract read
In one paragraph

Article in Drug metabolism and disposition: the biological fate of chemicals, 2013. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.6field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 16 citations in OpenAlex.

  1. Functional Expression of Multidrug Resistance Protein 4 MRP4/ABCC4.SLAS discovery : advancing life sciences R & D · 2019
    Article
  2. Article
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 2 countries.

Robert L MyetteDepartment of Pathology & Molecular Medicine, Queen’s University Cancer Research Institute, Kingston, Ontario, Canada.
Gwenaëlle Conseil
Sean P Ebert
Bryan Wetzel
Michael R Detty
Susan P C Cole
Queen's University · CAUniversity at Buffalo, State University of New York · US

Funding

Structural biology and high resolution studies of P-glycoproteinR01GM094367 · NIGMS · UNIVERSITY OF CALIFORNIA, SAN DIEGO · PI CHANG, GEOFFREY A · 2010 to 2013
$1.3M
CIHR MOP 10519NIGMS NIH HHS GM-94367NIGMS NIH HHS R01 GM094367
6 · The paper itself

Abstract

Multidrug resistance proteins (MRPs) mediate the ATP-dependent efflux of structurally diverse compounds, including anticancer drugs and physiologic organic anions. Five classes of chalcogenopyrylium dyes (CGPs) were examined for their ability to modulate transport of [(3)H]estradiol glucuronide (E(2)17βG; a prototypical MRP substrate) into MRP-enriched inside-out membrane vesicles. Additionally, some CGPs were tested in intact transfected cells using a calcein efflux assay. Sixteen of 34 CGPs inhibited MRP1-mediated E(2)17βG uptake by >50% (IC50 values: 0.7-7.6 µM). Of 9 CGPs with IC50 values ≤2 µM, two belonged to class I, two to class III, and five to class V. When tested in the intact cells, only 4 of 16 CGPs (at 10 µM) inhibited MRP1-mediated calcein efflux by >50% (III-1, V-3, V-4, V-6), whereas a fifth (I-5) inhibited efflux by just 23%. These five CGPs also inhibited [(3)H]E(2)17βG uptake by MRP4. In contrast, their effects on MRP2 varied, with two (V-4, V-6) inhibiting E(2)17βG transport (IC(50) values: 2.0 and 9.2 µM) and two (V-3, III-1) stimulating transport (>2-fold), whereas CGP I-5 had no effect. Strikingly, although V-3 and V-4 had opposite effects on MRP2 activity, they are structurally identical except for their chalcogen atom (Se versus Te). This study is the first to identify class V CGPs, with their distinctive methine or trimethine linkage between two disubstituted pyrylium moieties, as a particularly potent class of MRP modulators, and to show that, within this core structure, differences in the electronegativity associated with a chalcogen atom can be the sole determinant of whether a compound will stimulate or inhibit MRP2.

Indexed as

ATP-Binding Cassette, Sub-Family C ProteinsCell Line, TransformedChalcogensColoring AgentsHEK293 CellsHeterocyclic Compounds, 3-RingHumansIon TransportMultidrug Resistance-Associated Protein 2Organic Anion TransportersABCC2 protein, humanABCC4 protein, humanATP-Binding Cassette, Sub-Family C ProteinsChalcogensColoring AgentsHeterocyclic Compounds, 3-Ringmultidrug resistance-associated protein 1Multidrug Resistance-Associated Protein 2Organic Anion Transporterspyrylium 1

Identifiers

PMID23530018
PMCPMC3657094
OpenAlexW2072725007

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.